Skip to content
AnalystLens

Broadridge Financial Solutions 8-K Report, Regulation FD Disclosure (Nov 13, 2024)

Reports
Regulation FD·Exhibits & Filings
Filing Date
Filed November 13, 2024
Period End
November 12, 2024
Security
BR
In the record · 2016–202610-K1110-Q338-K224

BR filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 224 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Feb ’17Feb ’17
  2. Material agreement8-K · Jan ’20Jan ’20
  3. Leadership change8-K · Aug ’22Aug ’22
  4. Leadership change8-K · Jun ’26Jun ’26

01—Abstract

Summary

Summary of the 8-K filed November 13, 2024. Cited figures are marked; the original filing is the authoritative source.

Broadridge Financial Solutions, Inc. (BR) filed this Form 8-K under Item 7.01 (Regulation FD Disclosure) to furnish its November 2024 investor presentation, posted to its website on November 12, 2024, as Exhibit 99.1.

The filing itself contains no new financial statements; the investor presentation sets out the company's strategy across its Investor Communication Solutions (ICS) and Global Technology & Operations (GTO) franchises, its FY'24-26 three-year objectives, and its FY'25 guidance. The presentation reports first-quarter fiscal 2025 results: Recurring revenues of $900 milliona (up 3%), total revenues of $1,423 million, Diluted EPS of $0.68 (versus $0.76), Adjusted EPS of $1.00 (versus $1.09), and record Closed sales of $57 million. Management raised FY'25 Recurring revenue growth guidance (constant currency, non-GAAP) to 6-8% from 5-7%, and reaffirmed Adjusted EPS growth of 8-12%, Adjusted Operating income margin of about 20%, and Closed sales of $290-$330 million.

The company also cited the acquisition of Kyndryl's SIS business, which closed on November 1, 2024. The presentation states a three-year FY'24-26 objective of 7-9% Recurring revenue growth and 8-12% Adjusted EPS growth, with a capital allocation framework that targets roughly 100% free cash flow conversion and returns to shareholders through dividends and share repurchases. The FY'25 annual dividend amount is shown as $3.52b, subject to Board declaration.

02—Key points

Key Highlights

  1. Filed under Item 7.01 (Regulation FD); the November 2024 investor presentation is furnished as Exhibit 99.1 and is not deemed 'filed' under Section 18 of the Exchange Act.
  2. Q1 FY'25 Recurring revenues rose 3% to $900 million; Total revenues were $1,423 million, down from $1,431 million.
  3. Q1 FY'25 Diluted EPS was $0.68 versus $0.76, and Adjusted EPS (non-GAAP) was $1.00 versus $1.09.
  4. FY'25 Recurring revenue growth guidance (constant currency, non-GAAP) was raised to 6-8% from 5-7%; Adjusted EPS growth guidance of 8-12% was reaffirmed.
  5. FY'24-26 objectives include 7-9% Recurring revenue growth and 8-12% Adjusted EPS growth, with organic Recurring revenue growth of 5-8%.
  6. Closed sales were a record $57 million in Q1 FY'25, and FY'25 Closed sales guidance of $290-$330 million was unchanged.
  7. The Kyndryl SIS business acquisition closed on November 1, 2024, and the FY'25 dividend is shown at $3.52 per share, subject to Board approval.

03—Questions

Frequently Asked Questions

  1. Did this 8-K report new financial results?

    No. The 8-K furnishes an investor presentation under Item 7.01. The presentation includes Q1 FY'25 results previously discussed on the November 5, 2024 earnings call, along with updated guidance.

  2. How did Broadridge's first-quarter fiscal 2025 performance compare to the prior year?

    Recurring revenues increased 3% to $900 million from $871 million, while total revenues declined 1% to $1,423 million from $1,431 million. Operating income fell 9% to $134 million, and Adjusted EPS declined 8% to $1.00 from $1.09. Closed sales rose 21% to $57 million.

  3. What changed in the company's fiscal 2025 guidance?

    Recurring revenue growth constant currency guidance was raised to 6-8% from the prior 5-7%. Adjusted Operating income margin of about 20%, Adjusted EPS growth of 8-12%, and Closed sales of $290-$330 million were unchanged.

  4. What are the company's three-year financial objectives?

    For FY'24-26, Broadridge targets 7-9% Recurring revenue growth, including 5-8% organic growth, and 8-12% Adjusted EPS growth. The presentation states the company remains on track to achieve these objectives.

  5. What are the main risks to the business according to the filing?

    The forward-looking statements cite risks including changes in laws and regulations, reliance on a relatively small number of clients, cybersecurity attacks, declines in securities market activity, system failures, competition, failure to keep pace with technology, and the impact of acquisitions and divestitures. Investors are directed to the Risk Factors section of the 2024 Annual Report on Form 10-K.

04—Continue

← View all 8-K filings